| No headlines available for HBIOX. |
|
|
| Morningstar Overall Rating: |
 |
| Total Assets: |
202.36M |
| Category: |
Foreign Large Blend |
| Total Expense Ratio: |
0.96% |
|
| PERFORMANCE & RISK | 31-Jan-10
| YTD Return: |
-5.30% |
| 5y Avg Return: |
5.93% |
| Rank in Category (ytd): |
469 |
| % Rank in Category (ytd): |
54.98% |
| Beta (3y): |
1.02 |
| Morningstar Risk Rating: |
Average |
|
| The investment seeks long-term growth of capital. The fund normally invests at least 65% of assets in stocks issued by non-U.S. companies that trade in well-established foreign markets. It may also invest up to 25% of its total assets in securities of companies that conduct their principal business activities in emerging markets or whose securities are traded principally on exchanges in emerging markets. |
|
| Fund Profile |
|
Help
0.24 (2.36%) 
Summary
Add HBIOX to Portfolio 
Download Data
